CK Life Sciences International Holdings Inc (hkse:00775) Share Price

Company Profile

Business description
CK Life Sciences International Holdings Inc is an international life sciences company. It is engaged in research and development, manufacturing, commercialization, marketing and selling of health and agriculture-related products, as well as investment in a portfolio of vineyards, and various financial and investment products. Its pipeline includes Seviprotimut-L, TTX-MC138, Seviprotimut-L + TTX-MC138, TTX-RIGA, Halneuron, among others. Its segments include Agriculture-related, Nutraceutical, and Pharmaceuticals & Diagnostics R&D with the majority of the revenue deriving from Nutraceutical segment. Geographically it operates in Asia Pacific that derives the majority of the revenue and North America.
Contact
2 Dai Fu Street
Tai Po Industrial Estate
Tai Po
Hong Kong
HKG
T: +852 21261212
https://www.ck-lifesciences.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
1,920

Recommended

This ASX share remains overlooked despite a strong outlook.

Esther Holloway | 17 June 2026

Lower consumer spending unlikely to buckle this retail REIT.

Yingqi Tan, CFA | 16 June 2026

Sales growth but lack of margin expansion due to competition.

Johannes Faul, CFA | 15 June 2026

Index	Last price	Change	% Change
All Ordinaries	9,185.90	70.20	0.77%
CAC 40	8,476.45	29.18	0.35%
DAX 40	24,951.81	41.40	0.17%
Dow JONES (US)	51,999.67	328.64	0.64%
FTSE 100	10,492.58	1.63	-0.02%
HKSE	24,312.16	181.79	-0.74%
NASDAQ	26,376.34	307.60	-1.15%
Nikkei 225	69,902.25	497.75	0.72%
NZX 50 Index	13,392.98	33.15	-0.25%
S&P 500	7,511.35	42.94	-0.57%
S&P/ASX 200	8,966.30	65.50	0.74%
SSE Composite Index	4,108.08	16.18	0.40%